The markets are buzzing with speculation following reports that President Trump is considering reclassifying cannabis from a Schedule I to a Schedule III drug. While this is not the same as full federal legalization, it could reshape the industry in meaningful ways. For investors who have endured years of volatility in cannabis stocks, this potential policy shift may open new doors to profitability and growth.
Read More: Trump Weighs Reclassifying Cannabis: Buy Foreign Stocks
Comments are closed, but trackbacks and pingbacks are open.